Vifor Pharma AG announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CHF 859.3 million compared to CHF 846.2 million a year ago. Operating income was CHF 177.4 million compared to CHF 113.5 million a year ago. Net income was CHF 124.4 million compared to CHF 67.9 million a year ago. Basic earnings per share from continuing operations was CHF 1.92 compared to CHF 0.77 a year ago. Diluted earnings per share from continuing operations was CHF 1.91 compared to CHF 0.77 a year ago.